Novonesis (Novozymes) A/S

NSIS-B · Nasdaq Copenhagen · Basic materials

416.00DKK +0.7%last day

Price as of 2 October 2026

The price over the past year, with dividends: +10.7%

Performance

1 month

−7.7%

1 year

+10.7%

3 years, per year

+14.2%

5 years, per year

−1.0%

Largest fall, 3 years

−46.9%

Below the peak now

−15.5%

Volatility, 1 year

27.4%

Return with dividends reinvested.

Key figures

P/E

40.5

P/B

2.3

Dividend yield

1.6%

Return on equity

+5.7%

Net margin

+14.7%

Market value

29.2 bn USD

Quality, value and trend

Where Novonesis (Novozymes) stands against every Nordic stock today. 100 is best.

Quality93

Profitability and a sound balance sheet over time. Better than 93% of Nordic stocks.

Value27

The price measured against earnings, assets and cash flow. Better than 27% of Nordic stocks.

Trend65

The price development over the past year. Better than 65% of Nordic stocks.

Combined70

Quality, value and trend together. Better than 70% of Nordic stocks.

About Novonesis (Novozymes)

Novonesis (Novozymes) A/S is a company in basic materials, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 11,000 employees.

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis